Home » ART ANNOUNCES ALERION BIOMEDICAL, INC. ACQUISITION
ART ANNOUNCES ALERION BIOMEDICAL, INC. ACQUISITION
February 15, 2006
ART Advanced Research Technologies Inc., a Canadian medical device company and
a leader in optical molecular imaging products for the healthcare and pharmaceutical
industries, is pleased to announce that is has concluded a definitive agreement
to acquire substantially all of the imaging technology and product assets of Alerion
Biomedical, Inc., a US-based developer and manufacturer of biomarkers and contrast
media for preclinical and clinical imaging devices. This transaction is subject
to obtaining all necessary regulatory approvals, including that of the Toronto
Stock Exchange.
Business
Wire
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct